NCT07493902Recruiting
Acupuncture for Post-Stroke Dysphagia: A Clinical Study
Acupuncture Treatment for Post-Stroke Dysphagia: A Prospective, Multicenter Clinical Study of a Cohort-Based Embedded Partially Randomized Preference Trial
Source: ClinicalTrials.gov · Last updated 25 Mar 2026
Brief summary (registry, in English)
Employing a nested design, a partially randomized preference study (Study II) is embedded within a prospective, multicenter cohort study (Study I). The cohort study, with acupuncture as the exposure factor, explores the clinical efficacy and health economic value of different integrated Chinese and Western medicine treatment protocols. The nested partially randomized preference study of different acupuncture protocols generates high-level evidence through randomized cohorts while supplementing real-world decision-making with preference cohort data.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 3232 (estimated)
- First submitted
- 17 Mar 2026
- Start date
- Apr 2026
- Primary completion date
- Apr 2028
- Lead sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Diseases
- Stroke
- NCT number
- NCT07493902
What you commit to
- Study type: Interventional
- Planned participants: 3232
- From Apr 2026 to the primary completion date, Apr 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Dysphagia not caused by stroke, but resulting from other neurological disorders (e.g., motor neuron disease, myasthenia gravis) or organic lesions (e.g., tumors);
- Patients with psychiatric disorders or severe cognitive impairment who cannot cooperate with treatment;
- Patients with an expected survival time of less than 3 months; ④ Individuals with contrast medium allergy;
- Patients with severe needle phobia who cannot tolerate the procedure; ⑥ Pregnant women, those planning pregnancy, or lactating women; ⑦ Individuals who have participated in other clinical trials or received acupuncture within the past week.
Who the study is looking for
- Age between 18 and 80 years old, no gender restrictions;
- Meets diagnostic criteria for ischemic or hemorrhagic stroke, confirmed by CT or MRI, with disease duration within one year;
- Meets diagnostic criteria for dysphagia, with FOIS grade 2-4;
- Vital signs stable, able to understand and cooperate with study procedures; ⑤ Patient or legal representative agrees to sign informed consent.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xiaonong Fan Coordinator of this site? Confirm its status | Tianjin | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.